FDA Brief

Warning letters Drugs

FDA warning letter to

AstraZeneca Pharmaceuticals LP

Issued Aug 4, 2023Posted Aug 15, 2023The Office of Prescription Drug Promotion (OPDP)

False & Misleading Claims/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.